Phase Ib/II Study of Pembrolizumab with Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)

Administered By

Awarded By

Contributors

Start/End

  • December 13, 2016 - May 31, 2022